Press-release for stocks published on today related to biotech-beach

Prices are updated after-hours

Nexcella, an Immix Biopharma Subsidiary, on Track to Dose NXC-201 Patients in United States
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
IMMX | News | $2.25 -10.0% -11.11% 190K

| -3.6% | O: -3.6% H: 0.0% C: 0.0%
nxc-201 biopharma

| 0.25% | O: 0.25% H: 0.0% C: 0.0%
cell meeting therapeutics therapy

64%

36%

AGBA | News | $1.02 155.0% 57.94% 120M

ZCMD | $2.86 108.76% 52.1% 2.3M

INVO | $1.555 104.6% 51.13% 5M

ISPC | $0.437 105.16% 49.53% 37M

WLGS | News | $0.92 84.0% 45.65% 1.6M

OST | $0.499 21.38% 45.26% 1.9M

XPON | News | $3.1 60.62% 37.74% 17M

TIRX | $0.7 44.39% 30.74% 58M

BNTC | News | $6.92 44.17% 30.64% 3.5M

GGE | $0.035 19.86% 29.3% 64M

Save your searches and get alerts when important news are released.